Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drug Information Medical Encyclopedia Dictionary News Directories Other Resources

 

Medical Encyclopedia

Other encyclopedia topics:  A-Ag  Ah-Ap  Aq-Az  B-Bk  Bl-Bz  C-Cg  Ch-Co  Cp-Cz  D-Di  Dj-Dz  E-Ep  Eq-Ez  F  G  H-Hf  Hg-Hz  I-In  Io-Iz  J  K  L-Ln  Lo-Lz  M-Mf  Mg-Mz  N  O  P-Pl  Pm-Pz  Q  R  S-Sh  Si-Sp  Sq-Sz  T-Tn  To-Tz  U  V  W  X  Y  Z  0-9 

Sarcoidosis

Printer-friendly versionEmail this page to a friend
Contents of this page:

Illustrations

Sarcoid, stage I - chest X-ray
Sarcoid, stage I - chest X-ray
Sarcoid, stage II - chest X-ray
Sarcoid, stage II - chest X-ray
Sarcoid, stage IV - chest X-ray
Sarcoid, stage IV - chest X-ray
Sarcoid - close-up of the skin lesions
Sarcoid - close-up of the skin lesions
Erythema nodosum associated with sarcoidosis
Erythema nodosum associated with sarcoidosis
Sarcoidosis - close-up
Sarcoidosis - close-up
Sarcoidosis on the elbow
Sarcoidosis on the elbow
Sarcoidosis on the nose and forehead
Sarcoidosis on the nose and forehead
Respiratory system
Respiratory system

Definition    Return to top

Sarcoidosis is a disease of unknown cause in which inflammation occurs in the lymph nodes, lungs, liver, eyes, skin, and/or other tissues.

Causes, incidence, and risk factors    Return to top

The cause of the disease is unknown. Tissue samples from affected organs show clusters of immune cells (macrophages, lymphocytes, and multinucleated giant cells). These clusters are called granulomas.

Possible causes include a hypersensitive response to some factor in the environment, a genetic predisposition, or an extreme immune response to infection. The incidence varies widely according to race and sex.

The disease is most common among North Americans of African heritage and Northern European Caucasians. Women of African heritage are affected more than men of African heritage. The onset of the disease usually occurs in people between 30 and 50 years old. Sarcoidosis is very rare in young children.

Symptoms    Return to top

Additional symptoms that may be associated with this disease:

Note: There may be no symptoms.

Signs and tests    Return to top

This disease may also alter the results of the following tests:

Treatment    Return to top

Sarcoidosis symptoms often gradually resolve on their own without treatment.

Severely affected patients may require treatment with corticosteroids. Therapy may continue for one or two years, although some of the most severely affected may require life-long therapy.

Immunosuppressive agents, such as methotrexate, azathioprine, and cyclophosphamide, are sometimes used in addition to corticosteroids. Rarely, some individuals with irreversible organ failure require organ transplantation.

Expectations (prognosis)    Return to top

Many people are not seriously ill, and the disease may resolve without treatment. Thirty to fifty percent of cases resolve without treatment in 3 years. About 20% of those with lung involvement will develop residual lung damage. Death from sarcoidosis is rare.

Complications    Return to top

Calling your health care provider    Return to top

Call your health care provider if difficulty breathing, vision changes, palpitations, or other symptoms suggestive of this disorder develop.

Update Date: 2/6/2003

Updated by: David A. Kaufman, M.D., Pulmonary & Critical Care Medicine, University of Pennsylvania Medical Center, Philadelphia, PA. Review provided by VeriMed Healthcare Network.

adam.com logo

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2002 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.